Analysis of methylation status using oligonucleotide arrays

• US 20050009059A1
• Filed: 05/07/2004
• Published: 01/13/2005
• Est. Priority Date: 05/07/2003
• Status: Abandoned Application

• Current Assignee: Affymetrix, Inc. (Thermo Fisher Scientific Incorporated)
• Original Assignee: Affymetrix, Inc. (Thermo Fisher Scientific Incorporated)
• Inventors: Shapero, Michael H., Liu, Guoying
• Application Number:
  US10/841,027
• Publication Number:
  US 20050009059A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2521/313 Type II endonucleases, i.e. cutting outside recognition site
• CPC Class Codes: C12Q 2523/125 Bisulfite(s)
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides

Abstract

The present invention provides for novel methods and kits for determining the methylation status of a cytosine in a nucleic acid sample. The methylation status of a plurality of cytosines may be determined simultaneously. In one embodiment methylation status is determined using methylation specific modification of cytosines followed by locus specific amplification, single base extension at the interrogation position and identification of the extended base by array hybridization. In another embodiment methylation specific modification of a cytosine is detected by hybridization to an array of probes that are perfectly complementary to either the methylated product of modification or the unmethylated product of modification. In another embodiment methylation status is determined using methylation specific restriction enzymes coupled with hybridization to an array.

Claims

1. A method for determining if a cytosine in a target sequence in a nucleic acid sample is methylated comprising:

fragmenting the nucleic acid sample to generate fragments;

treating the sample with an agent that modifies unmethylated cytosines but does not modify methylated cytosines;

ligating an adaptor to the fragments, said adaptor comprising a first common sequence;

hybridizing a capture probe to the target sequence wherein the capture probe comprises a second common sequence, a tag sequence, a recognition sequence for a type IIs restriction enzyme and a region that is complementary to a region of the target sequence 3′

of the cytosine;

extending the capture probe to generate an extended capture probe;

amplifying the extended capture probe with first and second common sequence primers to generate double stranded extended capture probes;

digesting the amplified product with a Type IIS restriction enzyme to generate restriction fragments;

extending the restriction fragments in the presence of at least one labeled ddNTP;

hybridizing the restriction fragments to an array of oligonucleotides comprising a probe that is complementary to the tag sequence;

analyzing the hybridization pattern to determine the identity of labeled ddNTPs incorporated into the restriction fragments; and

determining the methylation status of the cytosine from the identity of labeled ddNTPs incorporated.

2. The method of claim 1 wherein the restriction fragments are extended in the presence of ddGTP and ddATP in separate reactions and hybridized to separate arrays.

3. The method of claim 1 wherein the restriction fragments are extended in the presence of ddCTP and ddTTP in separate reactions and hybridized to separate arrays.

4. The method of claim 1 wherein the step of modifying unmethylated cytosines in the nucleic acid sample is by treatment with sodium bisulfite.

5. The method of claim 4 wherein the labeled ddNTPs incorporated are ddGTP and the cytosine is determined to be methylated.

6. The method of claim 4 wherein the labeled ddNTPs incorporated are ddATP and the cytosine is determined to be unmethylated.

7. The method of claim 4 wherein the labeled ddNTPs incorporated are ddGTP and ddATP and the methylation status of the cytosine is determined to be a mixture of methylated and unmethylated.

8. The method of claim 7 wherein a ratio of methylated to unmethylated cytosines is determined.

9. The method of claim 1 wherein the labeled ddNTP is labeled with biotin.

10. The method of claim 1 wherein the step of modifying unmethylated cytosines in the nucleic acid sample occurs before the step of ligating an adaptor to the fragments.

11. The method of claim 1 wherein the step of modifying unmethylated cytosines in the nucleic acid sample occurs before the step of fragmenting the nucleic acid sample.

12. The method of claim 1 wherein prior to amplification the extended capture probe is enriched in the sample to be amplified.

13. The method of claim 1 wherein the capture probe is extended in the presence of labeled dNTPs to generate labeled extended capture probes and the labeled extended capture probes are isolated by affinity chromatography.

14. The method of claim 10 wherein said labeled dNTPs are labeled with biotin and labeled extended capture probes are isolated using avidin, streptavidin or an anti-biotin antibody.

15. The method of claim 1 wherein prior to amplification the extended capture probes are made double stranded and single stranded nucleic acid in the sample is digested with a single strand specific nuclease.

16. The method of claim 1 wherein prior to amplification the extended capture probe is circularized and uncircularized nucleic acid in the sample is digested.

17. The method of claim 1 wherein the nucleic acid sample is fragmented by digestion with one or more restriction enzymes.

18. The method of claim 1 wherein one of the common sequence primers is resistant to nuclease digestion and after the step of extending the restriction fragments and prior to the step of hybridizing the restriction fragments to an array the reaction is digested with a 5′

to 3′

nuclease activity.

19. The method of claim 18 wherein the nuclease activity is T7 Gene 6 Exonuclease.

20. The method of claim 1 wherein at least one of the common sequence primers comprises phosphorothioate linkages.

21. The method of claim 1 wherein the nucleic acid sample comprises genomic DNA.

22. The method of claim 1 wherein the nucleic acid sample comprises human genomic DNA.

27. A method for identifying the methylation status of a cytosine in a population of individuals comprising:

providing a nucleic acid sample from each individual;

determining the methylation status of the cytosine in each sample according to the method of claim 1;

and

comparing the methylation status of the cytosine to determine the presence or absence of variation in the population of individuals.

23. A method for determining the methylation status of at least one cytosine in each of a plurality of different target sequences in a nucleic acid sample comprising:

fragmenting the nucleic acid sample;

ligating an adaptor to the fragments, said adaptor comprising a first common sequence;

modifying unmethylated cytosines in the nucleic acid sample;

hybridizing the sample to a plurality of capture probes wherein each capture probe comprises a second common priming sequence, a common recognition sequence for a type IIS restriction enzyme, a tag sequence that is unique for each species of capture probe, and a region that hybridizes to a target sequence 3′

of a cytosine of interest and is unique for each species of capture probe;

extending the capture probes to generate an extended capture probes;

amplifying the extended capture probes with first and second common sequence primers;

digesting the amplified fragments with a Type IIS restriction enzyme to generate restriction fragments;

extending the restriction fragments in the presence of at least one labeled ddNTP;

hybridizing the restriction fragments to an array of oligonucleotides comprising probes that are complementary to the tag sequences; and

analyzing the hybridization pattern to determine the identity of labeled ddNTPs incorporated into the restriction fragments.

24. A method for determining the methylation status of a cytosine in a target sequence in a nucleic acid sample comprising:

fragmenting the nucleic acid sample to generate fragments;

differentially modifying methylated and unmethylated cytosines in the nucleic acid sample;

hybridizing a capture probe to the target sequence so that the 3′

end of the capture probe is adjacent to the cytosine and wherein the capture probe comprises a first common sequence, a tag sequence unique for each species of capture probe, and a region that hybridizes to the target sequence adjacent to the cytosine;

extending the capture probe to generate an extended capture probe;

hybridizing a target specific reverse primer to the extended capture probe wherein the locus specific reverse primer comprises a second common sequence and a target specific region that hybridizes to the target sequence 3′

of the cytosine and wherein either the capture probe or the target specific reverse primer comprises a recognition site for a type IIS restriction enzyme;

extending the target specific reverse primer to generate double stranded extended capture probe;

amplifying the double stranded extended capture probe with first and second common sequence primers;

digesting the amplified product with a Type IIS restriction enzyme to generate restriction fragments;

extending the restriction fragments in the presence of at least one labeled ddNTP;

hybridizing the restriction fragments to an array of oligonucleotides comprising a probe that is complementary to the tag sequence;

analyzing the hybridization pattern to determine the identity of labeled ddNTPs incorporated into the restriction fragments; and

determining the methylation status of the cytosine from the identify of labeled ddNTP incorporated.

25. The method of claim 24 wherein the capture probe comprises a recognition sequence for a type IIS restriction enzyme.

26. The method of claim 24 wherein the target specific reverse primer comprises a recognition sequence for a type IIS restriction enzyme.

28. A kit for determining the methylation status of a cytosine present in a target sequence in a plurality of target sequences said kit comprising:

a collection of capture probes, wherein each species of capture probe comprises a first common sequence, a tag sequence unique for each species of capture probe, a first target specific sequence, a Type IIS restriction enzyme recognition sequence positioned to cleave immediately 5′

of a cytosine of interest, and a second target specific sequence;

an adaptor comprising a first strand comprising a second common sequence and a second strand that does not contain the complement of the second common sequence and is blocked from extension at the 3′

end; and

a pair of first and second common sequence primers.

29. A method of determining if a selected cytosine is methylated in a nucleic acid sample comprising;

in a first step, fragmenting the genomic DNA sample with a first enzyme;

in a second step, ligating an adaptor to the fragments to generate adaptor-ligated genomic fragments;

in a third step, dividing the sample into three portions; and

fragmenting the first portion with a first restriction enzyme that cleaves methylated DNA;

fragmenting the second portion with a second enzyme that is a methylation sensitive isoschizomer of the first enzyme; and

leaving the third portion of the sample untreated;

in a fourth step, amplifying each of the portions with a primer to the adaptor sequence;

in a fifth step separately hybridizing each of the amplified portions to an array of probes wherein the array interrogates the presence or absence of a plurality of sequences in the genomic sample; and

in a sixth step analyzing the hybridization patterns to determine presence or absence of a fragment in each portion wherein a fragment that is present in the second and third portions but not in the first portion indicates presence of methylated cytosine.

30. The method of claim 29 wherein the nucleic acid sample is human genomic DNA.

31. The method of claim 29 where the first enzyme is MspI and the second enzyme is HpaII.

32. The method of claim 29 wherein the array of probes is a genotyping array.

33. A method of determining the methylation status of a plurality of cytosines in a sample comprising:

fragmenting genomic DNA from the sample with a restriction enzyme;

modifying the fragments with sodium bisulfite;

ligating an adaptor sequence to the fragments;

amplifying at least a subset of the fragments;

labeling the amplified fragments;

hybridizing the fragments to an array of probes, wherein the array comprises a first set of probes comprises a plurality of probes that are each perfectly complementary to a subsequence of a target sequence wherein the subsequence comprises a cytosine to be interrogated for methylation and a second set of probes that corresponds to the first set of probes except that the positions that are complementary to cytosines in the target are changed to adenines.

34. The method of claim 33 wherein the methylation status of more than 100 different cytosines are determined in parallel.

35. The method of claim 33 wherein the methylation status of more than 1000 different cytosines are determined in parallel.

36. The method of claim 33 wherein the methylation status of more than 10,000 different cytosines are determined in parallel.

37. The method of claim 33 wherein the methylation status of more than 100,000 different cytosines are determined in parallel.

38. The method of claim 33 wherein the first set of probes is selected to interrogate targets that are predicted by a computer system to contain a methylation site and to be amplified when the human genome is digested with a selected restriction enzyme and amplified by PCR.

39. The method of claim 33 wherein the array further comprises a third set of probes that comprises a set of mismatch probes corresponding to the first set of probes and a fourth set of probes that comprises a set of mismatch probes corresponding to the second set of probes.